Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval for Uplizna, now approved as a treatment for immunoglobulin G4-related ...

CVS Health has made a move ... AbbVie's Humira (adalimumab) recently approved as Hyrimoz. A new version is set for launch in the US under a Cordavis label in early 2024 at an 80% discount to ...

Often, there was no label approval file whatsoever—apparently ... Industry-backed certification programs such as CARE Certified, One Health Certified, and FACTA Certified mimic legitimate third-party ...

ILUVIEN now approved for the treatment of chronic non ... ANI plans to begin marketing ILUVIEN in the U.S. under the combined label later this year Nikhil Lalwani, President and CEO of ANI stated ...

Vertex Pharmaceuticals (VRTX) announced that the European Commission has granted regulatory approval for a label expansion of ... and provisions for access in health care systems such as Germany ...